View ValuationFuchs 향후 성장Future 기준 점검 1/6Fuchs (는) 각각 연간 6.4% 및 3.5% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 8.8% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 15.3% 로 예상됩니다.핵심 정보6.4%이익 성장률8.76%EPS 성장률Chemicals 이익 성장38.9%매출 성장률3.5%향후 자기자본이익률15.30%애널리스트 커버리지Good마지막 업데이트21 May 2026최근 향후 성장 업데이트공시 • May 02Fuchs SE Reaffirms Earnings Guidance for the Year 2025Fuchs SE reaffirmed earnings guidance for the year 2025. For the year, the company expects sales revenues around EUR 3.7 billion and EBIT around EUR 460 million.공시 • Mar 22Fuchs SE Provides Earnings Guidance for the Year 2025Fuchs SE provided earnings guidance for the year 2025. For the year, the company expects sales revenues around EUR 3.7 billion and EBIT around EUR 460 million.모든 업데이트 보기Recent updates공시 • Mar 26+ 1 more updateFuchs SE, Annual General Meeting, May 06, 2026Fuchs SE, Annual General Meeting, May 06, 2026, at 10:00 W. Europe Standard Time.공시 • Jan 27+ 1 more updateFuchs SE to Report Q3, 2026 Results on Oct 30, 2026Fuchs SE announced that they will report Q3, 2026 results at 7:00 AM, Central European Standard Time on Oct 30, 2026공시 • May 02Fuchs SE Reaffirms Earnings Guidance for the Year 2025Fuchs SE reaffirmed earnings guidance for the year 2025. For the year, the company expects sales revenues around EUR 3.7 billion and EBIT around EUR 460 million.공시 • Mar 27Fuchs SE, Annual General Meeting, May 07, 2025Fuchs SE, Annual General Meeting, May 07, 2025, at 10:00 W. Europe Standard Time.공시 • Mar 23Fuchs SE Proposes Dividend for the Year 2024Fuchs SE proposed to the annual general meeting a dividend increase by 5%, to EUR 1.16 (EUR 1.10) per ordinary share for the year 2024.공시 • Mar 22Fuchs SE Provides Earnings Guidance for the Year 2025Fuchs SE provided earnings guidance for the year 2025. For the year, the company expects sales revenues around EUR 3.7 billion and EBIT around EUR 460 million.Reported Earnings • Nov 01Third quarter 2024 earnings releasedThird quarter 2024 results: Revenue: €902.0m (up 3.0% from 3Q 2023). Net income: €80.0m (up 3.9% from 3Q 2023). Profit margin: 8.9% (up from 8.8% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.7% p.a. on average during the next 3 years, compared to a 6.2% decline forecast for the Chemicals industry in the United Kingdom.공시 • Oct 16+ 2 more updatesFuchs SE to Report Q1, 2025 Final Results on Apr 30, 2025Fuchs SE announced that they will report Q1, 2025 final results on Apr 30, 2025공시 • Sep 13Fuchs SE (XTRA:FPE3) signed a letter of intent to acquire Strub & Co. Ag.Fuchs SE (XTRA:FPE3) signed a letter of intent to acquire Strub & Co. Ag on September 13, 2024. For the period ending December 31, 2023, Strub & Co. Ag reported total revenue of €15 million. The transaction to be completed by the end of 2024.공시 • Aug 29Fuchs SE to Report Fiscal Year 2024 Results on Mar 21, 2025Fuchs SE announced that they will report fiscal year 2024 results on Mar 21, 2025Reported Earnings • Aug 01Second quarter 2024 earnings released: EPS: €0.59 (vs €0.50 in 2Q 2023)Second quarter 2024 results: EPS: €0.59 (up from €0.50 in 2Q 2023). Revenue: €887.0m (flat on 2Q 2023). Net income: €78.0m (up 15% from 2Q 2023). Profit margin: 8.8% (up from 7.7% in 2Q 2023). Revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 5.8% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Reported Earnings • May 01First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: €877.0m (down 6.3% from 1Q 2023). Net income: €77.0m (up 5.5% from 1Q 2023). Profit margin: 8.8% (up from 7.8% in 1Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 3.8% p.a. on average during the next 3 years, compared to a 2.7% decline forecast for the Chemicals industry in the United Kingdom.공시 • Apr 24Fuchs SE (XTRA:FPE3) signed an agreement to acquire Lubricant Consult Gmbh (Gesellschaft FÜR Schmier- Und GrenzflÄChenaktive Stoffe).Fuchs SE (XTRA:FPE3) signed an agreement to acquire Lubricant Consult Gmbh (Gesellschaft FÜR Schmier- Und GrenzflÄChenaktive Stoffe) on April 22, 2024. As of financial year 2023, Lubricant Consult reported a sales revenue of €40 million. The transaction is subject to approval from the cartel authorities and is expected to close in the third quarter of 2024.Reported Earnings • Mar 13Full year 2023 earnings releasedFull year 2023 results: Revenue: €3.54b (up 3.8% from FY 2022). Net income: €282.0m (up 8.9% from FY 2022). Profit margin: 8.0% (up from 7.6% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.0% p.a. on average during the next 3 years, compared to a 3.9% decline forecast for the Chemicals industry in the United Kingdom.공시 • Dec 08Fuchs SE Appoints Dr. Timo Reister as Deputy Chairman of the Executive BoardThe Supervisory Board of FUCHS SE has appointed Dr. Timo Reister (44) as Deputy Chairman of the Executive Board. The appointment will take effect from January 1, 2024 and is part of the company's long-term succession planning. Timo Reister joined FUCHS in 2009 after studying business administration and completing his doctorate and has been a member of the Executive Board based in Mannheim since 2016. After joining the company, he was responsible for the OEM and specialty business in the USA as well as for FUCHS Mexico for almost five years. He then moved to China in 2014, where he headed the Asia-Pacific region as a member of the Group Management Committee. Through these stays, Timo Reister got to know FUCHS' two most important foreign markets on the ground. At present, he is responsible for the two global regions Americas and Asia-Pacific as well as for three global sales divisions: OEM, Automotive Aftermarket and Mining. The responsibilities of the Executive Board remain unchanged by this appointment. In addition to Stefan FUCHS (55) and Dr. Timo Reister (44), the at the end of 2022 newly formed Executive Board team consists of Isabelle Adelt (39), CFO, Dr. Sebastian Heiner (45), CTO, and Dr. Ralph Rheinboldt responsible for the EMEA region (Europe, Africa and Middle East) and the Industry and Specialties divisions.Reported Earnings • Oct 28Third quarter 2023 earnings releasedThird quarter 2023 results: EPS: €0.57. Revenue: €876.0m (down 2.9% from 3Q 2022). Net income: €77.0m (up 10.0% from 3Q 2022). Profit margin: 8.8% (up from 7.8% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 5.8% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.Buying Opportunity • Oct 26Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 6.2%. The fair value is estimated to be €43.46, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has grown by 8.5%. Revenue is forecast to grow by 3.6% in 2 years. Earnings is forecast to grow by 19% in the next 2 years.공시 • Oct 24+ 3 more updatesFuchs SE, Annual General Meeting, May 08, 2024Fuchs SE, Annual General Meeting, May 08, 2024.공시 • Sep 12Fuchs SE to Report Fiscal Year 2023 Results on Mar 12, 2024Fuchs SE announced that they will report fiscal year 2023 results Pre-Market on Mar 12, 2024공시 • Sep 05Fuchs SE (XTRA:FPE3) acquired the remaining 35% stake in Fuchs lubricants SpA from Comercial Pacific Ltda..Fuchs SE (XTRA:FPE3) acquired the remaining 35% stake in Fuchs lubricants SpA from Comercial Pacific Ltda. on September 1, 2023. Fuchs SE (XTRA:FPE3) completed the acquisition of the remaining 35% stake in Fuchs lubricants SpA from Comercial Pacific Ltda. on September 1, 2023.Reported Earnings • Jul 30Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: €886.0m (up 6.5% from 2Q 2022). Net income: €68.0m (up 12% from 2Q 2022). Profit margin: 7.7% (up from 7.3% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 2.4% p.a. on average during the next 3 years, compared to a 5.9% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.Upcoming Dividend • Apr 27Upcoming dividend of €1.07 per share at 2.9% yieldEligible shareholders must have bought the stock before 04 May 2023. Payment date: 08 May 2023. Payout ratio is a comfortable 57% but the company is paying out more than the cash it is generating. Trailing yield: 2.9%. Lower than top quartile of British dividend payers (5.8%). Higher than average of industry peers (2.3%).Reported Earnings • Mar 09Full year 2022 earnings released: EPS: €1.87 (vs €1.82 in FY 2021)Full year 2022 results: EPS: €1.87 (up from €1.82 in FY 2021). Revenue: €3.41b (up 19% from FY 2021). Net income: €259.0m (up 2.4% from FY 2021). Profit margin: 7.6% (down from 8.8% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.6% p.a. on average during the next 3 years, compared to a 1.5% growth forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 8% per year and the company’s share price has also increased by 8% per year.공시 • Jan 02+ 3 more updatesFuchs Petrolub SE, Annual General Meeting, May 03, 2023Fuchs Petrolub SE, Annual General Meeting, May 03, 2023.Reported Earnings • Oct 30Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: €902.0m (up 26% from 3Q 2021). Net income: €70.0m (up 15% from 3Q 2021). Profit margin: 7.8% (down from 8.5% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 8.6% decline forecast for the Chemicals industry in the United Kingdom.공시 • Oct 25Fuchs Petrolub SE to Report Fiscal Year 2022 Results on Mar 08, 2023Fuchs Petrolub SE announced that they will report fiscal year 2022 results on Mar 08, 2023Valuation Update With 7 Day Price Move • Sep 29Investor sentiment improved over the past weekAfter last week's 65% share price gain to €43.87, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 17x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 44% over the past three years.Valuation Update With 7 Day Price Move • Sep 14Investor sentiment improved over the past weekAfter last week's 60% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 18x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 36% over the past three years.Valuation Update With 7 Day Price Move • Aug 30Investor sentiment improved over the past weekAfter last week's 59% share price gain to €43.87, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 18x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 50% over the past three years.Valuation Update With 7 Day Price Move • Aug 15Investor sentiment improved over the past weekAfter last week's 54% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 49% over the past three years.Reported Earnings • Aug 01Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: €832.0m (up 17% from 2Q 2021). Net income: €61.0m (down 6.2% from 2Q 2021). Profit margin: 7.3% (down from 9.1% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 4.7% compared to a 20% decline forecast for the industry in the United Kingdom.Valuation Update With 7 Day Price Move • Jul 27Investor sentiment improved over the past weekAfter last week's 52% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 35% over the past three years.Valuation Update With 7 Day Price Move • Jul 12Investor sentiment improved over the past weekAfter last week's 63% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 31% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €80.44 per share.Valuation Update With 7 Day Price Move • Jun 27Investor sentiment improved over the past weekAfter last week's 75% share price gain to €43.87, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 17x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 32% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €84.69 per share.Valuation Update With 7 Day Price Move • Jun 10Investor sentiment improved over the past weekAfter last week's 50% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 17x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 36% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €74.01 per share.Valuation Update With 7 Day Price Move • May 26Investor sentiment improved over the past weekAfter last week's 59% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 18x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 34% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €77.33 per share.Valuation Update With 7 Day Price Move • May 06Investor sentiment improved over the past weekAfter last week's 46% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 20x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 33% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €77.38 per share.Reported Earnings • May 01First quarter 2022 earnings releasedFirst quarter 2022 results: Revenue: €808.0m (up 16% from 1Q 2021). Net income: €67.0m (down 5.6% from 1Q 2021). Profit margin: 8.3% (down from 10% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 6.9% compared to a 16% decline forecast for the industry in the United Kingdom.Upcoming Dividend • Apr 27Upcoming dividend of €1.03 per shareEligible shareholders must have bought the stock before 04 May 2022. Payment date: 06 May 2022. Payout ratio is a comfortable 57% but the company is paying out more than the cash it is generating. Trailing yield: 3.4%. Lower than top quartile of British dividend payers (4.6%). Higher than average of industry peers (2.7%).Valuation Update With 7 Day Price Move • Apr 01Investor sentiment improved over the past weekAfter last week's 32% share price gain to €43.87, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 24% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €62.33 per share.Valuation Update With 7 Day Price Move • Mar 16Investor sentiment improved over the past weekAfter last week's 39% share price gain to €43.87, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 24% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €71.38 per share.Valuation Update With 7 Day Price Move • Mar 01Investor sentiment improved over the past weekAfter last week's 21% share price gain to €43.87, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 20x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 19% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €65.29 per share.Valuation Update With 7 Day Price Move • Feb 14Investor sentiment improved over the past weekAfter last week's 15% share price gain to €43.87, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 21x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 14% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €61.71 per share.Valuation Update With 7 Day Price Move • Jan 25Investor sentiment improved over the past weekAfter last week's 16% share price gain to €43.87, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 22x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 15% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €60.27 per share.Reported Earnings • Nov 03Third quarter 2021 earnings released: EPS €0.44The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: €718.0m (up 16% from 3Q 2020). Net income: €61.0m (down 3.2% from 3Q 2020). Profit margin: 8.5% (down from 10% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has increased by 2% per year.Valuation Update With 7 Day Price Move • Oct 12Investor sentiment improved over the past weekAfter last week's 15% share price gain to €43.87, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 24x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 2.4% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €61.82 per share.Reported Earnings • Aug 01Second quarter 2021 earnings releasedThe company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €714.0m (up 42% from 2Q 2020). Net income: €65.0m (up 132% from 2Q 2020). Profit margin: 9.1% (up from 5.6% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year whereas the company’s share price has fallen by 5% per year.Reported Earnings • May 04First quarter 2021 earnings releasedThe company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €697.0m (up 13% from 1Q 2020). Net income: €71.0m (up 39% from 1Q 2020). Profit margin: 10% (up from 8.3% in 1Q 2020). The increase in margin was driven by higher revenue.Upcoming Dividend • Apr 28Upcoming dividend of €0.99 per shareEligible shareholders must have bought the stock before 05 May 2021. Payment date: 07 May 2021. Trailing yield: 2.2%. Lower than top quartile of British dividend payers (4.1%). Higher than average of industry peers (1.6%).Reported Earnings • Mar 10Full year 2020 earnings released: EPS €1.58 (vs €1.64 in FY 2019)The company reported a soft full year result with weaker earnings and revenues, although profit margins were improved. Full year 2020 results: Revenue: €2.38b (down 7.5% from FY 2019). Net income: €220.0m (down 3.5% from FY 2019). Profit margin: 9.3% (up from 8.9% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.Analyst Estimate Surprise Post Earnings • Mar 10Revenue beats expectationsRevenue exceeded analyst estimates by 0.1%. Over the next year, revenue is forecast to grow 8.6% compared to a 9.5% decline forecast for the Chemicals industry in the United Kingdom.Is New 90 Day High Low • Feb 26New 90-day low: €45.38The company is down 6.0% from its price of €48.16 on 27 November 2020. The British market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €42.92 per share.Is New 90 Day High Low • Feb 08New 90-day high: €49.44The company is up 6.0% from its price of €46.68 on 10 November 2020. The British market is also up 6.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €44.43 per share.Is New 90 Day High Low • Nov 11New 90-day high: €47.62The company is up 24% from its price of €38.30 on 13 August 2020. The British market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €39.96 per share.Analyst Estimate Surprise Post Earnings • Nov 05Revenue beats expectationsRevenue exceeded analyst estimates by 14%. Over the next year, revenue is forecast to grow 4.2% compared to a 14% decline forecast for the Chemicals industry in the United Kingdom.Is New 90 Day High Low • Oct 17New 90-day high: €45.98The company is up 20% from its price of €38.16 on 17 July 2020. The British market is down 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €40.29 per share.Is New 90 Day High Low • Sep 29New 90-day high: €42.62The company is up 19% from its price of €35.72 on 01 July 2020. The British market is down 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €39.66 per share.이익 및 매출 성장 예측LSE:0LCR - 애널리스트 향후 추정치 및 과거 재무 데이터 (EUR Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/20284,152378341457812/31/20274,0693463264421012/31/20263,97632121930593/31/20263,573318343441N/A12/31/20253,563306314406N/A9/30/20253,559295294382N/A6/30/20253,565291319406N/A3/31/20253,572302309394N/A12/31/20243,525302307390N/A9/30/20243,509299328402N/A6/30/20243,483296369442N/A3/31/20243,482286426505N/A12/31/20233,541282460543N/A9/30/20233,568279417499N/A6/30/20233,594272220303N/A3/31/20233,54026595173N/A12/31/20223,41225959128N/A9/30/20223,2842541491N/A6/30/20223,10024576148N/A3/31/20222,98224971147N/A12/31/20212,87125389169N/A9/30/20212,767275159237N/A6/30/20212,669277235331N/A3/31/20212,459240273379N/A12/31/20202,378220238360N/A9/30/20202,360194203343N/A6/30/20202,396195174310N/A3/31/20202,545224158309N/A12/31/20192,572228N/A329N/A9/30/20192,566245N/A271N/A6/30/20192,552260N/A233N/A3/31/20192,567276N/A275N/A12/31/20182,567288N/A267N/A9/30/20182,564290N/A280N/A6/30/20182,537275N/A274N/A3/31/20182,498270N/A225N/A12/31/20172,473269N/A242N/A9/30/20172,426266N/A256N/A6/30/20172,378266N/A288N/A3/31/20172,335266N/A313N/A12/31/20162,267259N/A300N/A9/30/20162,243246N/A308N/A6/30/20162,207244N/A296N/A3/31/20162,136238N/A286N/A12/31/20152,079236N/A281N/A9/30/20152,002236N/A278N/A6/30/20151,954233N/A277N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 0LCR 의 연간 예상 수익 증가율(6.4%)이 saving rate(3.4%)보다 높습니다.수익 vs 시장: 0LCR 의 연간 수익(6.4%)이 UK 시장(11.5%)보다 느리게 성장할 것으로 예상됩니다.고성장 수익: 0LCR 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.수익 대 시장: 0LCR 의 수익(연간 3.5%)이 UK 시장(연간 4.5%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: 0LCR 의 수익(연간 3.5%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 0LCR의 자본 수익률은 3년 후 15.3%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/22 18:27종가2026/05/22 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Fuchs SE는 28명의 분석가가 다루고 있습니다. 이 중 10명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Konstantin WiechertBaader Helvea Equity ResearchVolker BosseBaader Helvea Equity ResearchAnil ShenoyBarclays25명의 분석가 더 보기
공시 • May 02Fuchs SE Reaffirms Earnings Guidance for the Year 2025Fuchs SE reaffirmed earnings guidance for the year 2025. For the year, the company expects sales revenues around EUR 3.7 billion and EBIT around EUR 460 million.
공시 • Mar 22Fuchs SE Provides Earnings Guidance for the Year 2025Fuchs SE provided earnings guidance for the year 2025. For the year, the company expects sales revenues around EUR 3.7 billion and EBIT around EUR 460 million.
공시 • Mar 26+ 1 more updateFuchs SE, Annual General Meeting, May 06, 2026Fuchs SE, Annual General Meeting, May 06, 2026, at 10:00 W. Europe Standard Time.
공시 • Jan 27+ 1 more updateFuchs SE to Report Q3, 2026 Results on Oct 30, 2026Fuchs SE announced that they will report Q3, 2026 results at 7:00 AM, Central European Standard Time on Oct 30, 2026
공시 • May 02Fuchs SE Reaffirms Earnings Guidance for the Year 2025Fuchs SE reaffirmed earnings guidance for the year 2025. For the year, the company expects sales revenues around EUR 3.7 billion and EBIT around EUR 460 million.
공시 • Mar 27Fuchs SE, Annual General Meeting, May 07, 2025Fuchs SE, Annual General Meeting, May 07, 2025, at 10:00 W. Europe Standard Time.
공시 • Mar 23Fuchs SE Proposes Dividend for the Year 2024Fuchs SE proposed to the annual general meeting a dividend increase by 5%, to EUR 1.16 (EUR 1.10) per ordinary share for the year 2024.
공시 • Mar 22Fuchs SE Provides Earnings Guidance for the Year 2025Fuchs SE provided earnings guidance for the year 2025. For the year, the company expects sales revenues around EUR 3.7 billion and EBIT around EUR 460 million.
Reported Earnings • Nov 01Third quarter 2024 earnings releasedThird quarter 2024 results: Revenue: €902.0m (up 3.0% from 3Q 2023). Net income: €80.0m (up 3.9% from 3Q 2023). Profit margin: 8.9% (up from 8.8% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.7% p.a. on average during the next 3 years, compared to a 6.2% decline forecast for the Chemicals industry in the United Kingdom.
공시 • Oct 16+ 2 more updatesFuchs SE to Report Q1, 2025 Final Results on Apr 30, 2025Fuchs SE announced that they will report Q1, 2025 final results on Apr 30, 2025
공시 • Sep 13Fuchs SE (XTRA:FPE3) signed a letter of intent to acquire Strub & Co. Ag.Fuchs SE (XTRA:FPE3) signed a letter of intent to acquire Strub & Co. Ag on September 13, 2024. For the period ending December 31, 2023, Strub & Co. Ag reported total revenue of €15 million. The transaction to be completed by the end of 2024.
공시 • Aug 29Fuchs SE to Report Fiscal Year 2024 Results on Mar 21, 2025Fuchs SE announced that they will report fiscal year 2024 results on Mar 21, 2025
Reported Earnings • Aug 01Second quarter 2024 earnings released: EPS: €0.59 (vs €0.50 in 2Q 2023)Second quarter 2024 results: EPS: €0.59 (up from €0.50 in 2Q 2023). Revenue: €887.0m (flat on 2Q 2023). Net income: €78.0m (up 15% from 2Q 2023). Profit margin: 8.8% (up from 7.7% in 2Q 2023). Revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 5.8% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Reported Earnings • May 01First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: €877.0m (down 6.3% from 1Q 2023). Net income: €77.0m (up 5.5% from 1Q 2023). Profit margin: 8.8% (up from 7.8% in 1Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 3.8% p.a. on average during the next 3 years, compared to a 2.7% decline forecast for the Chemicals industry in the United Kingdom.
공시 • Apr 24Fuchs SE (XTRA:FPE3) signed an agreement to acquire Lubricant Consult Gmbh (Gesellschaft FÜR Schmier- Und GrenzflÄChenaktive Stoffe).Fuchs SE (XTRA:FPE3) signed an agreement to acquire Lubricant Consult Gmbh (Gesellschaft FÜR Schmier- Und GrenzflÄChenaktive Stoffe) on April 22, 2024. As of financial year 2023, Lubricant Consult reported a sales revenue of €40 million. The transaction is subject to approval from the cartel authorities and is expected to close in the third quarter of 2024.
Reported Earnings • Mar 13Full year 2023 earnings releasedFull year 2023 results: Revenue: €3.54b (up 3.8% from FY 2022). Net income: €282.0m (up 8.9% from FY 2022). Profit margin: 8.0% (up from 7.6% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.0% p.a. on average during the next 3 years, compared to a 3.9% decline forecast for the Chemicals industry in the United Kingdom.
공시 • Dec 08Fuchs SE Appoints Dr. Timo Reister as Deputy Chairman of the Executive BoardThe Supervisory Board of FUCHS SE has appointed Dr. Timo Reister (44) as Deputy Chairman of the Executive Board. The appointment will take effect from January 1, 2024 and is part of the company's long-term succession planning. Timo Reister joined FUCHS in 2009 after studying business administration and completing his doctorate and has been a member of the Executive Board based in Mannheim since 2016. After joining the company, he was responsible for the OEM and specialty business in the USA as well as for FUCHS Mexico for almost five years. He then moved to China in 2014, where he headed the Asia-Pacific region as a member of the Group Management Committee. Through these stays, Timo Reister got to know FUCHS' two most important foreign markets on the ground. At present, he is responsible for the two global regions Americas and Asia-Pacific as well as for three global sales divisions: OEM, Automotive Aftermarket and Mining. The responsibilities of the Executive Board remain unchanged by this appointment. In addition to Stefan FUCHS (55) and Dr. Timo Reister (44), the at the end of 2022 newly formed Executive Board team consists of Isabelle Adelt (39), CFO, Dr. Sebastian Heiner (45), CTO, and Dr. Ralph Rheinboldt responsible for the EMEA region (Europe, Africa and Middle East) and the Industry and Specialties divisions.
Reported Earnings • Oct 28Third quarter 2023 earnings releasedThird quarter 2023 results: EPS: €0.57. Revenue: €876.0m (down 2.9% from 3Q 2022). Net income: €77.0m (up 10.0% from 3Q 2022). Profit margin: 8.8% (up from 7.8% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 5.8% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.
Buying Opportunity • Oct 26Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 6.2%. The fair value is estimated to be €43.46, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has grown by 8.5%. Revenue is forecast to grow by 3.6% in 2 years. Earnings is forecast to grow by 19% in the next 2 years.
공시 • Oct 24+ 3 more updatesFuchs SE, Annual General Meeting, May 08, 2024Fuchs SE, Annual General Meeting, May 08, 2024.
공시 • Sep 12Fuchs SE to Report Fiscal Year 2023 Results on Mar 12, 2024Fuchs SE announced that they will report fiscal year 2023 results Pre-Market on Mar 12, 2024
공시 • Sep 05Fuchs SE (XTRA:FPE3) acquired the remaining 35% stake in Fuchs lubricants SpA from Comercial Pacific Ltda..Fuchs SE (XTRA:FPE3) acquired the remaining 35% stake in Fuchs lubricants SpA from Comercial Pacific Ltda. on September 1, 2023. Fuchs SE (XTRA:FPE3) completed the acquisition of the remaining 35% stake in Fuchs lubricants SpA from Comercial Pacific Ltda. on September 1, 2023.
Reported Earnings • Jul 30Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: €886.0m (up 6.5% from 2Q 2022). Net income: €68.0m (up 12% from 2Q 2022). Profit margin: 7.7% (up from 7.3% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 2.4% p.a. on average during the next 3 years, compared to a 5.9% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
Upcoming Dividend • Apr 27Upcoming dividend of €1.07 per share at 2.9% yieldEligible shareholders must have bought the stock before 04 May 2023. Payment date: 08 May 2023. Payout ratio is a comfortable 57% but the company is paying out more than the cash it is generating. Trailing yield: 2.9%. Lower than top quartile of British dividend payers (5.8%). Higher than average of industry peers (2.3%).
Reported Earnings • Mar 09Full year 2022 earnings released: EPS: €1.87 (vs €1.82 in FY 2021)Full year 2022 results: EPS: €1.87 (up from €1.82 in FY 2021). Revenue: €3.41b (up 19% from FY 2021). Net income: €259.0m (up 2.4% from FY 2021). Profit margin: 7.6% (down from 8.8% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.6% p.a. on average during the next 3 years, compared to a 1.5% growth forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 8% per year and the company’s share price has also increased by 8% per year.
공시 • Jan 02+ 3 more updatesFuchs Petrolub SE, Annual General Meeting, May 03, 2023Fuchs Petrolub SE, Annual General Meeting, May 03, 2023.
Reported Earnings • Oct 30Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: €902.0m (up 26% from 3Q 2021). Net income: €70.0m (up 15% from 3Q 2021). Profit margin: 7.8% (down from 8.5% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 8.6% decline forecast for the Chemicals industry in the United Kingdom.
공시 • Oct 25Fuchs Petrolub SE to Report Fiscal Year 2022 Results on Mar 08, 2023Fuchs Petrolub SE announced that they will report fiscal year 2022 results on Mar 08, 2023
Valuation Update With 7 Day Price Move • Sep 29Investor sentiment improved over the past weekAfter last week's 65% share price gain to €43.87, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 17x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 44% over the past three years.
Valuation Update With 7 Day Price Move • Sep 14Investor sentiment improved over the past weekAfter last week's 60% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 18x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 36% over the past three years.
Valuation Update With 7 Day Price Move • Aug 30Investor sentiment improved over the past weekAfter last week's 59% share price gain to €43.87, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 18x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 50% over the past three years.
Valuation Update With 7 Day Price Move • Aug 15Investor sentiment improved over the past weekAfter last week's 54% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 49% over the past three years.
Reported Earnings • Aug 01Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: €832.0m (up 17% from 2Q 2021). Net income: €61.0m (down 6.2% from 2Q 2021). Profit margin: 7.3% (down from 9.1% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 4.7% compared to a 20% decline forecast for the industry in the United Kingdom.
Valuation Update With 7 Day Price Move • Jul 27Investor sentiment improved over the past weekAfter last week's 52% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 35% over the past three years.
Valuation Update With 7 Day Price Move • Jul 12Investor sentiment improved over the past weekAfter last week's 63% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 31% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €80.44 per share.
Valuation Update With 7 Day Price Move • Jun 27Investor sentiment improved over the past weekAfter last week's 75% share price gain to €43.87, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 17x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 32% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €84.69 per share.
Valuation Update With 7 Day Price Move • Jun 10Investor sentiment improved over the past weekAfter last week's 50% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 17x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 36% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €74.01 per share.
Valuation Update With 7 Day Price Move • May 26Investor sentiment improved over the past weekAfter last week's 59% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 18x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 34% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €77.33 per share.
Valuation Update With 7 Day Price Move • May 06Investor sentiment improved over the past weekAfter last week's 46% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 20x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 33% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €77.38 per share.
Reported Earnings • May 01First quarter 2022 earnings releasedFirst quarter 2022 results: Revenue: €808.0m (up 16% from 1Q 2021). Net income: €67.0m (down 5.6% from 1Q 2021). Profit margin: 8.3% (down from 10% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 6.9% compared to a 16% decline forecast for the industry in the United Kingdom.
Upcoming Dividend • Apr 27Upcoming dividend of €1.03 per shareEligible shareholders must have bought the stock before 04 May 2022. Payment date: 06 May 2022. Payout ratio is a comfortable 57% but the company is paying out more than the cash it is generating. Trailing yield: 3.4%. Lower than top quartile of British dividend payers (4.6%). Higher than average of industry peers (2.7%).
Valuation Update With 7 Day Price Move • Apr 01Investor sentiment improved over the past weekAfter last week's 32% share price gain to €43.87, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 24% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €62.33 per share.
Valuation Update With 7 Day Price Move • Mar 16Investor sentiment improved over the past weekAfter last week's 39% share price gain to €43.87, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 24% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €71.38 per share.
Valuation Update With 7 Day Price Move • Mar 01Investor sentiment improved over the past weekAfter last week's 21% share price gain to €43.87, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 20x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 19% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €65.29 per share.
Valuation Update With 7 Day Price Move • Feb 14Investor sentiment improved over the past weekAfter last week's 15% share price gain to €43.87, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 21x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 14% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €61.71 per share.
Valuation Update With 7 Day Price Move • Jan 25Investor sentiment improved over the past weekAfter last week's 16% share price gain to €43.87, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 22x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 15% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €60.27 per share.
Reported Earnings • Nov 03Third quarter 2021 earnings released: EPS €0.44The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: €718.0m (up 16% from 3Q 2020). Net income: €61.0m (down 3.2% from 3Q 2020). Profit margin: 8.5% (down from 10% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has increased by 2% per year.
Valuation Update With 7 Day Price Move • Oct 12Investor sentiment improved over the past weekAfter last week's 15% share price gain to €43.87, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 24x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 2.4% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €61.82 per share.
Reported Earnings • Aug 01Second quarter 2021 earnings releasedThe company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €714.0m (up 42% from 2Q 2020). Net income: €65.0m (up 132% from 2Q 2020). Profit margin: 9.1% (up from 5.6% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year whereas the company’s share price has fallen by 5% per year.
Reported Earnings • May 04First quarter 2021 earnings releasedThe company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €697.0m (up 13% from 1Q 2020). Net income: €71.0m (up 39% from 1Q 2020). Profit margin: 10% (up from 8.3% in 1Q 2020). The increase in margin was driven by higher revenue.
Upcoming Dividend • Apr 28Upcoming dividend of €0.99 per shareEligible shareholders must have bought the stock before 05 May 2021. Payment date: 07 May 2021. Trailing yield: 2.2%. Lower than top quartile of British dividend payers (4.1%). Higher than average of industry peers (1.6%).
Reported Earnings • Mar 10Full year 2020 earnings released: EPS €1.58 (vs €1.64 in FY 2019)The company reported a soft full year result with weaker earnings and revenues, although profit margins were improved. Full year 2020 results: Revenue: €2.38b (down 7.5% from FY 2019). Net income: €220.0m (down 3.5% from FY 2019). Profit margin: 9.3% (up from 8.9% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.
Analyst Estimate Surprise Post Earnings • Mar 10Revenue beats expectationsRevenue exceeded analyst estimates by 0.1%. Over the next year, revenue is forecast to grow 8.6% compared to a 9.5% decline forecast for the Chemicals industry in the United Kingdom.
Is New 90 Day High Low • Feb 26New 90-day low: €45.38The company is down 6.0% from its price of €48.16 on 27 November 2020. The British market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €42.92 per share.
Is New 90 Day High Low • Feb 08New 90-day high: €49.44The company is up 6.0% from its price of €46.68 on 10 November 2020. The British market is also up 6.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €44.43 per share.
Is New 90 Day High Low • Nov 11New 90-day high: €47.62The company is up 24% from its price of €38.30 on 13 August 2020. The British market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €39.96 per share.
Analyst Estimate Surprise Post Earnings • Nov 05Revenue beats expectationsRevenue exceeded analyst estimates by 14%. Over the next year, revenue is forecast to grow 4.2% compared to a 14% decline forecast for the Chemicals industry in the United Kingdom.
Is New 90 Day High Low • Oct 17New 90-day high: €45.98The company is up 20% from its price of €38.16 on 17 July 2020. The British market is down 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €40.29 per share.
Is New 90 Day High Low • Sep 29New 90-day high: €42.62The company is up 19% from its price of €35.72 on 01 July 2020. The British market is down 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €39.66 per share.